Following WHO alert: LANXESS counters Mpox threat with Rely+On Virkon
- Effectiveness of Rely+On Virkon against Mpox pathogens scientifically proven
- Disinfection is the key to preventing transmission
In view of the increasing Mpox infections in Central and East Africa, the World Health Organization (WHO) has declared an international health emergency.
The disinfectant Rely+On Virkon from specialty chemicals company LANXESS has been proven to be effective against the Mpox virus, formerly known as the “monkeypox virus”. This is confirmed by independent tests that confirm the product's effectiveness against the virus.
“Especially in times of rising infection rates, the choice of an effective disinfectant that has been proven to kill the target pathogen is crucial,” says Roy van Wel, Head of the market segment Hygiene and Care at LANXESS.
Rely+On Virkon is used for the disinfection of hard surfaces in hospitals, healthcare facilities, airports, public transportation terminals, clinics, shopping malls and many other public places.
Rely+On Virkon has proven to be effective against the pathogen and supports prevention in risk areas. It provides effective inactivation of the virus on hard surfaces, helping to contain the spread.
For more information on Rely+On Virkon, click here.
Information for editors:
All global LANXESS news releases and their accompanying photos can be found at http://press.lanxess.com.
Recent photos of the Board of Management and other LANXESS image material are available at http://photos.lanxess.com.
